Custom
Request 

Research Report Details

Author / Researcher : Technavio

Report Statistics

Number Of Pages/Tabs : 70

Number Of Charts : N/A

Published Date : 08/26/2015

Industries : Healthcare and Medical Devices

Countries : All

Quality Score : 5

Have a question about this report?
24/7 Research Support
Talk to Zursh Analyst
+1 858 522 9998 or Email Us

Global Dry Eye Syndrome Market 2015-2019
About dry eye syndrome Dry eye syndrome usually results in dryness of eyes due to deficient tear production or quick tear evaporation or deviation in tear uniformity.

This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye.

Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity.

Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment.

Technavio's analysts forecast the global dry eye syndrome market to grow at a CAGR of 4.75% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global dry eye syndrome market for the period 2015-2019.

To calculate the market size, the report considers revenue generated from the sales of teardrops and anti-inflammatory drugs used in the treatment of dry eye syndrome.

Technavio's report, Global Dry Eye Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

It covers the market size and forecast as well as market segmentation. The report includes a discussion of the key vendors operating in this market. Key regions • Americas • APAC • EMEA Key vendors • Alcon • Allergan • Otsuka Holdings • Santen Pharmaceuticals Other prominent vendors • Acadia Pharmaceuticals • Aciex • Allostera Pharma • arGentis • Auven Therapeutics (Celtic) • Bridge Pharma • Can-Fite • Cellzome Key market driver • Growing prevalence of dry eye syndrome • For a full, detailed list, view our report Key market challenge • Self-medication by patients • For a full, detailed list, view our report Key market trend • Growing awareness about the syndrome • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?.

;

Companies Covered

Alcon, Allergan, Otsuka Holdings, Santen Pharmaceuticals, Acadia Pharmaceuticals, Aciex, Allostera Pharma, arGentis, Auven Therapeutics (Celtic), Bridge Pharma, Can-Fite, Cellzome
PART 01: Executive summary
 Highlights
PART 02: Scope of the report
 Market overview
 Top-vendor offerings
PART 03: Market research methodology
 Research methodology
 Economic indicators
PART 04: Introduction
 Key market highlights
PART 05: Disease overview
 Understanding dry eye syndrome
 Types of dry eye syndrome
 Risk factors for dry eye syndrome
 Signs and symptoms
 Causes of dry eye syndrome
 Epidemiology
 Diagnosis
 Disease management
PART 06: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis
PART 07: Pipeline analysis
 Cyclokat
 Diquas
 EBI-005
 MIM-D3
 Lifitegrast
 RGN-259
 EBI-005
 EGP-437
PART 08: Market segmentation by sub-type of dry eye
PART 09: Market segmentation by drug type
 Oral antibiotics
 Eye drops
 Eye inserts
 Eye ointments
PART 10: Geographical segmentation
 Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
 Competitive scenario
 Market share analysis 2014
 Other prominent vendors
PART 16: Key vendor analysis
 Alcon
 Allergan
 Otsuka Holdings
 Santen Pharmaceuticals
PART 17: Appendix
 List of abbreviations
PART 18: Explore Technavio
List of Exhibits  
Exhibit 01: Product offerings
Exhibit 02: Regional prevalence of dry eye syndrome
Exhibit 03: Diagnosis of dry eye syndrome
Exhibit 04: Surgical options
Exhibit 05: Punctal plugs
Exhibit 06: Global dry eye syndrome market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Market segmentation by sub-type of dry eye
Exhibit 09: Dry eye syndrome: pharmacologic therapy
Exhibit 10: Artificial tears: Different generations
Exhibit 11: Global dry eye syndrome market share 2014
Exhibit 12: Global dry eye syndrome: Key drivers
Exhibit 13: Impact of drivers
Exhibit 14: Global dry eye syndrome: Key challenges
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Global dry eye syndrome: Emerging trends
Exhibit 17: Global dry eye syndrome market share analysis 2014
Exhibit 18: Alcon: Business strategy
Exhibit 19: Alcon: Distribution of sales by category 2014
Exhibit 20: Alcon: Region-wise sales distribution 2014 ($ millions)
Exhibit 21: Alcon: Region-wise sales distribution 2013 ($ millions)
Exhibit 22: Systane: Global sales 2011-2014 ($ millions)
Exhibit 23: Allergan: Business strategy
Exhibit 24: Eye care pharmaceuticals: Global sales 2011-2014 ($ millions)
Exhibit 25: Restasis: Global sales 2011-2014 ($ millions)
Exhibit 26: Santen Pharmaceuticals: Business strategy
Exhibit 27: Hyalein: Global sales 2011-2014 ($ millions)
Exhibit 28: Diquas: Global sales 2011-2014 ($ millions)
Exhibit 29: Prescription ophthalmics : Global sales 2011-2014 ($ millions)
Exhibit 30: Alcon: Business segmentation 2014
Exhibit 31: Allergan: Business segmentation by revenue 2014
Exhibit 32: Allergan: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 33: Allergan: Geographical segmentation by revenue 2014
Exhibit 34: Santen Pharmaceutical: Business/Product segmentation 2014 by revenue

Summary of Source & Methodology

True

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Download additional documents & original sources used by researcher/publisher to support the report data

Download Documents
No documents available for download

Zursh quality control analysts have developed a nice rating algorithm to independently and objectively evaluate the quality of this report.

Quality Score : 5
Content 5
Reputation 5
Sources 5
Presentation 5
Technavio is a market research company with global coverage. Their research and analysis focuses on emerging market trends help businesses to identify market opportunities and develop effective strategies to optimize their market positions.

Technavio models the market trends using a mix of quantitative and qualitative tools in its proprietary research methodologies. Their team of over 300 specialized analysts continuously monitors and evaluates the market landscape and builds forecasts across market segments and geographical regions based on the trends identified.

Founded in 2003 and headquartered in London, UK, Technavio has offices across North America, Europe, and Asia. Covering more than 100 industries across 50 countries, they develop over 5,000 research deliverables every year.